Metformin for breast cancer less effective at higher glucose concentrations

A new study shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome. Patients with high glucose may require higher doses of the drug metformin to achieve the same anti-cancer activity as patients with normal glucose levels.

Read the whole article on Science Daily

More from Science Daily